James H. Garvin, MD, Ph.D., is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is the Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was the principal investigator for a Children's Oncology Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in the Developmental Therapeutics Program of the COG.

In addition, Dr. Garvin started the pediatric bone marrow transplant program and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients.

Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field.